Automation, Innovation, And The Future Of Drug Safety

The International Data Corporation reveals a significant annual increase of 30% to 50% in safety caseloads, necessitating the adoption of emerging technologies to manage this surge. How does cutting-edge technology such as generative AI contribute to advancements in safety and pharmacovigilance? Is touchless case processing a beneficial development, or does it pose potential drawbacks? Moreover, how do we strike a balance between the utilization of AI, automation, and maintaining the human element in this domain?

Join us in this episode featuring Bruce Palsulich, Vice President of Safety Solutions at Oracle Life Sciences. With over three decades of experience in healthcare and life sciences, including 25 years dedicated to pharmacovigilance, Bruce oversees leading solutions like Argus Safety and Empirica Signal, setting standards in adverse event case processing, analytics, signal detection, and risk management.